Medical Practitioners, Researchers and Mental Health Professionals in Melbourne are invited to join a Q&A session in August with Dr Martijn Arns, leading researcher in the areas of TMS in Depression, OCD and Neurofeedback in ADHD and Sleep Disorders.
neuroCare's Susanne Mechtersheimer will take part in the UNSW's Learning Difference Convention, detailed the HOP (homework, Organisation and Planning Skills) Program
A study at the University of Southern California has investigated the link between digital media use and the development of ADHD-related behaviours among 15- and 16-year-olds. This study highlights a potential association between digital media and behavioural symptoms typically associated with ADHD.
neuroCare has established a global network of clinics and training centres, now in Australia, for professionals interested in EEG Biofeedback and Neurostimulation techniques, proven to have beneficial and sustainable effects in mental health.
New study shows brain activity measured by QEEG can help predict which children may or may not respond to medications for ADHD
Researchers compare methods of treating ADHD in children and find that Neurofeedback, a medication-free technique, has long-lasting effects, according to a recent study published in the medical journal European Child & Adolescent Psychiatry.
Researchers find cost of rTMS treatment to be more cost-effective as compared to antidepressant medication trials, factoring in financial commitment and quality of life post treatment.
New study shows that magnetic brain stimulation (TMS) combined with concurrent psychotherapy is more effective than either technique alone with 66% of research subjects with Depression responding well in an average of 21 session. 65% of the group achieved long-term benefit.
Members of the Royal Australian and New Zealand College of Psychiatry are putting forward a new submission to have TMS subsidized under Australia’s public health fund, Medicare.
neuroCare is innovating mental health and performance by personalising therapy following a detailed assessment. neuroCare’s objective, measurable and effective approach is based on our natural ability to learn (neuroplasticity) and technology to accelerate the learning (neuromodulation).
To learn more about what we do worldwide
www.neurocaregroup.com
neuroCademy Professional Training & Science
www.neurocademy.com
